Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

International Endeavors Excited About California Marijuana Legalization


Posted on: 04 Jan 18

TEMECULA, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE — International Endeavors Corp (OTC:IDVV) is pleased to announce the following:

The arrival of 2018 in California brought with it broad legalization of marijuana, a much-anticipated change that comes two decades after the state was the first to allow pot for medical use.

The nation’s most populous state joins a growing list of other states, and the nation’s capital, where recreational marijuana is permitted even though the federal government continues to classify pot as a controlled substance.

Marijuana is now legal in California for adults 21 and older, and individuals can grow up to six plants and possess as much as an ounce of the drug.

In 1996, despite objections of law enforcement, President Clinton’s drug czar and three former presidents, California voters approved marijuana for medicinal purposes. Twenty years later, voters approved legal recreational use and gave the state a year to write regulations for a legal market that would open in 2018.

Today, 29 states have adopted medical marijuana laws. In 2012, Colorado and Washington became the first states to legalize recreational marijuana. Since then, five more states have passed recreational marijuana laws, including Massachusetts, where retail sales are scheduled to begin in July.

Even with other states as models, the next year is expected to be a bumpy one in California as more shops open and more stringent regulations take effect.

At first, pot shops will be able to sell marijuana harvested without full regulatory controls. But eventually, the state will require extensive testing for potency, pesticides and other contaminants. A program to track all pot from seed to sale will be phased in, along with other protections such as childproof containers.

International Endeavors Corporation is excited about the opportunities being created. In 2017 the company announced its partnership with Steve Kubby and Kubby Cryogenics. Together IEC and Kubby are working on developing and Patenting specific strains to treat specific ailments as well as a proprietary extraction method which captures the highest medical value of any product known on the market today.

In addition to the relationship with Kubby, IEC is developing other forms of IP related to the container marketplace to take advantage of the new regulations coming in California.

Mr. Steve Kubby Bio
Steven Wynn "Steve" Kubby played a key role in the passage of California Proposition 215, a ballot initiative passed in 1996 to legalize medical marijuana. He is a well-known cancer patient of 36 years, who benefits his recovery through the use of non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby was formally Chairman and CEO of Cannabis Sativa Inc., traded under the symbol CBDS, and has authored 2 books on drug policy reform. Mr. Kubby’s distinguished political career includes runs for Governor of California in 1998, and the 2008 Presidential primary race under the libertarian ticket.

About International Endeavors Corporation
International Endeavors Corporation is a company focused on biomedical uses of non-psychoactive cannabis based products for the treatment of a wide variety of illnesses. Through a unique patent pending Cryogenic process, the Company can process different unique medical grade cannabis strains that are genetically profiled to treating specific diseases. www.internationalendeavorscorp.com

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Nate Engel
CEO
Phone: 951-2961024
Email: nate@internationalendeavorscorp.com

GlobeNewswire
globenewswire.com

Last updated on: 04/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.